SCHEMBL4474842

SCHEMBL4474842

CCCCCCCC/C=C\CCCCCCCC(=O)C(C)OC(C)C(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 3/20 0.58
PTPN1 P18031 3/20 0.58
PPARG P37231 3/20 0.58
PPARD Q03181 3/20 0.58
PPARA Q07869 3/20 0.58
CYP1A2 P05177 2/20 0.58
MAPT P10636 2/20 0.58
CYP2C19 P33261 2/20 0.58
BLM P54132 2/20 0.58
HSD17B10 Q99714 2/20 0.58
FABP4 P15090 2/20 0.58
FAAH O00519 2/20 0.58
KMT2A Q03164 2/20 0.58
F7 P08709 2/20 0.58
F3 P13726 2/20 0.58
DUSP3 P51452 2/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
LMNA P02545 1/20 0.58
POLB P06746 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11693884 1.00 TERT (0.58) TERTPTPN1PPARGPPARDPPARA
SCHEMBL28803423 0.89 CES2 (0.57) MAPTFAAHKMT2ALMNAMEN1
SCHEMBL21452297 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL21452029 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL21451223 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL23950153 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL23950132 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL23950452 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL21448814 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA
SCHEMBL23572558 0.84 TERT (0.63) TERTPTPN1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005447-A1 METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-01-01 US disclosed
US-7423066-B2 Dietetics; use in treatment of obesity, for reducing body weight, modulating body lipid metabolism, and reducing food intake THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-09-09 US disclosed
US-20080103209-A1 Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-05-01 US disclosed
EP-1677780-A4 DIETARY AND OTHER COMPOSITIONS, COMPOUNDS, AND METHODS FOR REDUCING BODY FAT, CONTROLLING APPETITE, AND MODULATING FATTY ACID METABOLISM UNIV CALIFORNIA (US) 2007-05-02 EP disclosed
EP-1742626-A2 COMPOUNDS AND METHODS FOR TREATING NON-INFLAMMATORY PAIN USING PPARALPHA AGONISTS The Regents of The University of California (US) 2007-01-17 EP disclosed
EP-1677780-A2 DIETARY AND OTHER COMPOSITIONS, COMPOUNDS, AND METHODS FOR REDUCING BODY FAT, CONTROLLING APPETITE, AND MODULATING FATTY ACID METABOLISM The Regents of the University of California (US) 2006-07-12 EP disclosed
WO-2005115370-A2 COMPOUNDS AND METHODS FOR TREATING NON-INFLAMMATORY PAIN USING PPARALPHA AGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-08 WO disclosed
US-20050187254-A1 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-08-25 US disclosed
US-20050154064-A1 Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-07-14 US disclosed
EP-1408945-A4 METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM UNIV CALIFORNIA (US) 2005-07-06 EP disclosed
US-6911474-B2 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-06-28 US disclosed
WO-2005046580-A2 DIETARY AND OTHER COMPOSITIONS, COMPOUNDS, AND METHODS FOR REDUCING BODY FAT, CONTROLLING APPETITE, AND MODULATING FATTY ACID METABOLISM THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-05-26 WO disclosed
US-20050054730-A1 Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-03-10 US disclosed
WO-2005002524-A2 COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-01-13 WO disclosed
EP-1408945-A2 METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM The Regents of the University of California (US) 2004-04-21 EP disclosed
US-20030018081-A1 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-01-23 US disclosed
WO-2002080860-A2 METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103209-A1 Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists FAAH, CNR2, FAAH2 TERT 4310/4885PTPN1 925/4885PPARG 6/4885
US-20090005447-A1 METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM LIPC, FABP4, FASN TERT 4546/4885PTPN1 4403/4885PPARG 80/4885
US-20030018081-A1 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism LIPC, FABP4, FASN TERT 4546/4885PTPN1 4403/4885PPARG 80/4885
US-20050187254-A1 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism LIPC, FABP4, FASN TERT 4546/4885PTPN1 4403/4885PPARG 80/4885
US-20050054730-A1 Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha PPARA, CNR2, CNR1 TERT 4152/4885PTPN1 3880/4885PPARG 11/4885
US-20050154064-A1 Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism FABP4, LIPC, FAAH TERT 4829/4885PTPN1 4058/4885PPARG 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.